Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 15, 2019 - Issue
Submit an article Journal homepage
134
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

John M Zajecka1 Department of Psychiatry, Rush University Medical Center, Chicago, IL, USA, [email protected];2 Psychiatric Medicine Associates, LLC, Skokie, IL, USA, [email protected]Correspondence[email protected]
,
Arielle D Stanford3 Department of Clinical Research, Alkermes, Inc., Waltham, MA, USA
,
Asli Memisoglu4 Department of Biostatistics, Alkermes, Inc., Waltham, MA, USA
,
William F Martin5 Clinical Operations, Alkermes, Inc., Waltham, MA, USA
&
Sanjeev Pathak3 Department of Clinical Research, Alkermes, Inc., Waltham, MA, USA
Pages 795-808 | Published online: 04 Apr 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.